Real-world, patient-reported outcome data accelerates discovery
Why PROM data matters
The future of drug development belongs to the patient. Our dataset captures real-time, longitudinal, patient-reported outcome measures (PROMs) that go beyond clinical metrics to reveal the real-world impact of therapies on daily life.
OutcomeMD collects this data across all of the patients in our system, which ensures that important relationships are surfaced. With these insights, you can make earlier, more confident decisions – reducing risk and increasing the likelihood of trial success.
- Diverse coverage – Multiple disease states and a wide range of patient demographics
- Standardized measures – Research-class PROMs for consistent benchmarking
- Longitudinal depth – Changes are tracked over time for sharper insights
- Nationwide scale – Data from across the U.S. is aggregated and de-identified
Use cases for biopharma and commercialization experts
Whether you’re preparing an IND, optimizing trial protocols, or expanding indications post-approval, the OutcomeMD dataset can give you a powerful competitive edge: faster insights and more relevant evidence highlight a clearer path from development to market. Your next breakthrough may already be discoverable in the data.
- Trial design – Identify patient segments, endpoints, and quality-of-life measures that improve study relevance and enrollment
- Market access – Support payer negotiations with real-world patient impact data
- Post-market surveillance – Monitor safety, efficacy, and patient experience after launch
How we obtain the data
OutcomeMD partners with healthcare providers across the U.S. to collect patient-reported outcomes before and after treatment.
- Patients securely complete validated assessment instruments on mobile devices or desktops
- Responses are integrated with relevant clinical data inside the provider’s EHR
- All data is de-identified in compliance with HIPAA and HITRUST standards before entering our research dataset
This approach ensures:
- High engagement rates – Patients respond because PROMs are tied directly to their ongoing care and improving their personal outcomes
- Rich, longitudinal data – Responses are captured at multiple time points throughout the patient journey
- Authentic real-world evidence – Data is collected in the patient’s natural environment, not an artificial setting
Gain often-elusive insights on patient quality of life
Quality of life can be difficult to measure in a clinical trial, but is often a key differentiator for your product. Real-world, quality-of-life data captured in a patient’s natural environment better informs both your research and marketing strategies.
The Patient Experience Data Network™ that provides the foundation for this data turns patient-reported outcome measures into actionable insights that help researchers unlock smarter discoveries.
Get direct access to the patient insights that can transform your next trial. Ready to see the data?
FAQs
How can OutcomeMD’s de-identified PROM dataset be used?
Our dataset provides a powerful foundation for assessing treatment impact, tracking clinical milestones, and conducting in-depth analyses of safety, efficacy, and patient quality of life.
What PROMs are included?
OutcomeMD’s dataset covers hundreds of validated PROMs across primary care, oncology, mental health, surgery, and chronic diseases, and more. We can also collaborate to identify specific measures tailored to your specific research or trial needs.
How can OutcomeMD accelerate discovery?
By integrating longitudinal patient-reported outcomes with clinical data, our dataset delivers rich, real-world evidence that reveals trends, surfaces new opportunities, and enables faster, better-informed decisions throughout the development cycle.
What data is collected?
Depending on the specialty and treatment, the dataset may include symptom severity, functional status, treatment impacts, efficacy measures, and quality-of-life indicators – captured over time and ready to integrate with your internal datasets for a more complete analysis.